...
首页> 外文期刊>Instrumenta Analytical Instrument Industry Report >Corbett purchase fills Qiagen's instrumentation gap
【24h】

Corbett purchase fills Qiagen's instrumentation gap

机译:购买Corbett填补了Qiagen的仪器仪表空白

获取原文
获取原文并翻译 | 示例
           

摘要

Qiagen NV (Venlo, The Netherlands), which has previously designed its molecular testing technologies under an open platform approach for the PCR detection instruments of other manufacturers, has acquired the privately-held Corbett Life Science pty Ltd (Sydney, Australia) and is to increase its focus on developing tests for its own-brand instruments, it said. Qiagen will pay around 70 million in cash and stock for the company, plus a potential 65 million over the next four years in performance-related payments.
机译:Qiagen NV(荷兰Venlo)以前曾在开放平台方法下为其他制造商的PCR检测仪器设计其分子测试技术,现已收购了私人持有的Corbett Life Science pty Ltd(澳大利亚悉尼),并将该公司表示,将更加专注于开发自有品牌乐器的测试。 Qiagen将为该公司支付大约7000万现金和股票,此外,在未来四年中还将支付与绩效相关的付款6500万。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号